mTOR inhibitor AZD8055 significantly reduced the tumor and metastatic burden in athymic nude mice injected with cells of the metastatic mouse pheochromocytoma-derived cell line, MTT, and decreased survival of primary human pheochromocytoma cells in culture (145). Here, MTOR is linked to hereditary pheochromocytoma-paraganglioma.